상세 보기
Tumor clearance, T-cell fitness, and minimal residual disease (MRD) outcomes in patients with relapsed/refractory multiple myeloma (RRMM) treated with cevostamab plus pomalidomide and dexamethasone: Biomarker analyses from CAMMA 1 Arm B
- Harrison, Simon;
- Riley, Caroline Hasselbalch;
- Mian, Hira;
- Spencer, Andrew;
- Lavi, Noa;
- ... Kim, Kihyun;
- 외 13명
Citations
WEB OF SCIENCE
1- 제목
- Tumor clearance, T-cell fitness, and minimal residual disease (MRD) outcomes in patients with relapsed/refractory multiple myeloma (RRMM) treated with cevostamab plus pomalidomide and dexamethasone: Biomarker analyses from CAMMA 1 Arm B
- 저자
- Harrison, Simon; Riley, Caroline Hasselbalch; Mian, Hira; Spencer, Andrew; Lavi, Noa; Paris, Laura; Mihalyova, Jana; Popat, Rakesh; Szarejko, Monika; Grosicki, Sebastian; Kim, Kihyun; Sandhu, Irwindeep; Chebon, Sammy; Tyagi, Tulika; Sewpaul, Paresh; Richardson, Leanne; Trunzer, Kerstin; Mishra, Ameet; Trudel, Suzanne
- 발행일
- 2025-11-03
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146
- 페이지
- 252 ~ 253